Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"-Reference-Cited by-同舟云学术

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

Published:2016-02-21 Issue:5 Volume:5 Page:333-335
ISSN:2322-5939
Container-title:International Journal of Health Policy and Management
language:en
Short-container-title:Int J Health Policy Manag

Author:

Doran Evan

Publisher

Maad Rayan Publishing Company

Subject

Health Policy,Health Information Management,Leadership and Management,Management, Monitoring, Policy and Law,Health (social science)

Link

http://ijhpm.com/article_3165_edf6de02e707bcb04cafbb318879722c.pdf

Reference12 articles.

1. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic?;Ventola CL;P T,2011

2. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

3. A Prompt to the Web: The Media and Health Information Seeking Behaviour

4. Drug promotion in Australia: policy contestation and the tightening of regulation;Doran E;Australian Review of Public Affairs,2013

5. The Cost-Effectiveness of Direct-to-Consumer Advertising for Prescription Drugs

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender bias in antidepressant direct-to-consumer pharmaceutical advertising;Comprehensive Psychiatry;2023-05

2. Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries;International Journal of Health Policy and Management;2016-07-10